Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Melanoma × Exercise Test × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Lung Neoplasms 7 Colorectal Neoplasms 5 Prostatic Neoplasms 4 Hodgkin Disease 4 Hematologic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 2 Obesity 2 Neoplasms 2 Multiple Myeloma 2 Motor Activity 2 Lymphoma, Non-Hodgkin 2 Hematopoietic and Lymphoid System Neoplasm 2 Gastrointestinal Diseases 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Trastuzumab Cardiotoxicity 1 Sedentary Behavior 1 Sarcopenia 1 Polycystic Ovary Syndrome 1 Pelvic Neoplasms 1 Pathologically Proven Gastrointestinal Malignancy 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Myocardial Fibrosis 1 Myelodysplastic Syndromes 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Malignant Solid Neoplasm 1

Interventions

Nivolumab 122 Ipilimumab 113 pembrolizumab 105 Cyclophosphamide 67 Interleukin-2 57 aldesleukin 53 Temozolomide 35 trametinib 34 Radiosurgery 34 Vemurafenib 32 Biopsy 31 dabrafenib 30 fludarabine 29 Radiotherapy 27 Blood Specimen Collection 27 sargramostim 26 fludarabine phosphate 25 Bevacizumab 25 Introns 21 Magnetic Resonance Spectroscopy 20 Dacarbazine 20 Specimen Handling 17 cobimetinib 16 Paclitaxel 16 Granulocyte-Macrophage Colony-Stimulating Factor 16 Cisplatin 16 encorafenib 15 binimetinib 15 incomplete Freund's adjuvant 14 Radiation 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06008977 2025-06-04

EX-BOOST

AdventHealth Translational Research Institute

Phase NA Recruiting

Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡